Fingerprint
Dive into the research topics of 'Metabolism and disposition of the anticancer quinolone derivative vosaroxin, a novel inhibitor of topoisomerase II'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Metabolism and disposition of the anticancer quinolone derivative vosaroxin, a novel inhibitor of topoisomerase II
Cynthia M Nijenhuis, L. Lucas, H. Rosing, Alwin D R Huitema, M. Mergui-Roelvink, G C Jamieson, Andrew J Fox, D.R. Mould, J H M Schellens, J H Beijnen
- Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, The Netherlands. [email protected].
- Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, The Netherlands.
- Netherlands Cancer Institute
- Sunesis Pharmaceuticals, Inc., South San Francisco, CA, USA.
- Projections Research, Inc., Phoenixville, PA, USA.
Research output: Contribution to journal › Article › Academic › peer-review